ERISnp®

About Eye Pharma

Eye Pharma is a private, Italy-based biopharmaceutical company dedicated to advancing ophthalmology treatments through targeted R&D. The company is developing an innovative platform leveraging liposomal technology to enhance drug delivery and efficacy for ocular surface diseases, with its lead program, ERISnp®, targeting dry eye syndrome. While currently in the development stage and likely pre-revenue, Eye Pharma positions itself as an avant-garde player aiming to address unmet medical needs with high-value therapeutic solutions. Its strategy involves collaborations with top research centers and a commitment to ecological sustainability.

Therapeutic Areas